2023
DOI: 10.1016/s2468-2667(23)00082-8
|View full text |Cite
|
Sign up to set email alerts
|

Mortality among individuals prescribed opioid-agonist therapy in Scotland, UK, 2011–20: a national retrospective cohort study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 21 publications
(14 citation statements)
references
References 20 publications
1
5
0
Order By: Relevance
“…Other potential limitations of our analysis concern unmeasured time‐varying confounders. The observed calendar year effect showed clear evidence of variation over time in Scotland, which is consistent with studies showing increasing DRM risk (since at least 2010 [2, 29]) and changes in environmental risk (e.g. polydrug and benzodiazepine use [2]).…”
Section: Discussionsupporting
confidence: 87%
“…Other potential limitations of our analysis concern unmeasured time‐varying confounders. The observed calendar year effect showed clear evidence of variation over time in Scotland, which is consistent with studies showing increasing DRM risk (since at least 2010 [2, 29]) and changes in environmental risk (e.g. polydrug and benzodiazepine use [2]).…”
Section: Discussionsupporting
confidence: 87%
“…Unmet health needs have been linked to increased depression, with 29% (21-37%) of PWUD meeting the threshold for clinical depression diagnosis, and consequent self-harm and post-traumatic stress common [ 1 , 137 ]. There were also associations between experience of addictions treatment and overdose which were unexpected, given OAT is known to be protective against drug-related mortality [ 138 ]. This association may be explained by severity of dependence (and related suboptimal dosage); changes in tolerance whilst engaging with treatment; those who engaged with treatment having a higher likelihood of follow-up for overdose; those with past overdose experience being more likely to be referred for treatment; OAT discontinuity and re-entry; and transferring between OAT providers [ 139 , 140 ].…”
Section: Discussionmentioning
confidence: 99%
“…As part of public health initiatives, a number of countries now provide naloxone kits for use by first responders in an effort to tackle drug related deaths within communities (Speakman et al, 2023). For those who are opioid dependent 'take home naloxone' may be administered in the event of an accidental overdose, and prior to hospital admission (McAuley et al, 2023).…”
Section: Naloxone Hydrochloride For Acute Life Threating Opioid Eventsmentioning
confidence: 99%